BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 22496273)

  • 1. Endothelial microparticles: missing link in endothelial dysfunction?
    Yong PJ; Koh CH; Shim WS
    Eur J Prev Cardiol; 2013 Jun; 20(3):496-512. PubMed ID: 22496273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial microparticles: sophisticated vesicles modulating vascular function.
    Curtis AM; Edelberg J; Jonas R; Rogers WT; Moore JS; Syed W; Mohler ER
    Vasc Med; 2013 Aug; 18(4):204-14. PubMed ID: 23892447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial microparticles: Pathogenic or passive players in endothelial dysfunction in autoimmune rheumatic diseases?
    McCarthy EM; Wilkinson FL; Parker B; Alexander MY
    Vascul Pharmacol; 2016 Nov; 86():71-76. PubMed ID: 27291140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial microparticles as conveyors of information in atherosclerotic disease.
    Schiro A; Wilkinson FL; Weston R; Smyth JV; Serracino-Inglott F; Alexander MY
    Atherosclerosis; 2014 Jun; 234(2):295-302. PubMed ID: 24721189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, cell differentiation, angiogenesis--microparticles and their roles in angiogenesis.
    Shai E; Varon D
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):10-4. PubMed ID: 21160063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The many faces of endothelial microparticles.
    Dignat-George F; Boulanger CM
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):27-33. PubMed ID: 21160065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating CD31+/CD42b-EMPs in Perthes disease and inhibit HUVECs angiogenesis via endothelial dysfunction.
    Li B; Huang Q; Lin C; Lu R; Wang T; Chen X; Liu Z; Liu Y; Wu J; Wu Y; Liao S; Ding X
    Life Sci; 2021 Jan; 265():118749. PubMed ID: 33220290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticles: a component of various diseases.
    Budaj M; Poljak Z; Ďuriš I; Kaško M; Imrich R; Kopáni M; Maruščáková L; Hulín I
    Pol Arch Med Wewn; 2012; 122 Suppl 1():24-9. PubMed ID: 23222474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?
    Tushuizen ME; Diamant M; Sturk A; Nieuwland R
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):4-9. PubMed ID: 21160062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function.
    Klinkner DB; Densmore JC; Kaul S; Noll L; Lim HJ; Weihrauch D; Pritchard KA; Oldham KT; Sander TL
    Shock; 2006 Jun; 25(6):575-80. PubMed ID: 16721264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-kinase-dependent F-actin rearrangement is involved in the release of endothelial microparticles during IFN-α-induced endothelial cell apoptosis.
    Gao C; Li R; Liu Y; Ma L; Wang S
    J Trauma Acute Care Surg; 2012 Nov; 73(5):1152-60. PubMed ID: 23117378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial injury and repair in systemic vasculitis of the young.
    Clarke LA; Hong Y; Eleftheriou D; Shah V; Arrigoni F; Klein NJ; Brogan PA
    Arthritis Rheum; 2010 Jun; 62(6):1770-80. PubMed ID: 20178138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microparticles, vascular function and hypertension.
    Boulanger CM
    Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):177-80. PubMed ID: 20051854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells.
    Burger D; Touyz RM
    J Am Soc Hypertens; 2012; 6(2):85-99. PubMed ID: 22321962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circulating endothelial cells, microparticles and progenitors: towards the definition of vascular competence].
    Sabatier F; Lacroix R; Camoin-Jau L; Anfosso F; Sampol J; Dignat-George F
    Rev Med Interne; 2011 Jan; 32(1):54-63. PubMed ID: 20541851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.
    Amabile N; Guérin AP; Tedgui A; Boulanger CM; London GM
    Nephrol Dial Transplant; 2012 May; 27(5):1873-80. PubMed ID: 22036944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction.
    Hosseinzadeh S; Noroozian M; Mortaz E; Mousavizadeh K
    Metab Brain Dis; 2018 Feb; 33(1):293-299. PubMed ID: 29209923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endothelial progenitor cells and endothelial microparticles in patients with arterial erectile dysfunction and metabolic syndrome.
    La Vignera S; Condorelli R; Vicari E; D'Agata R; Calogero AE
    J Androl; 2012; 33(2):202-9. PubMed ID: 21474787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-derived microparticles inhibit angiogenesis in the heart and enhance the inhibitory effects of hypercholesterolemia on angiogenesis.
    Ou ZJ; Chang FJ; Luo D; Liao XL; Wang ZP; Zhang X; Xu YQ; Ou JS
    Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E661-8. PubMed ID: 21245463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunction.
    Marei I; Chidiac O; Thomas B; Pasquier J; Dargham S; Robay A; Vakayil M; Jameesh M; Triggle C; Rafii A; Jayyousi A; Al Suwaidi J; Abi Khalil C
    Cardiovasc Diabetol; 2022 Feb; 21(1):17. PubMed ID: 35109843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.